Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Jeeyun Lee, Samsung Medical Center
ClinicalTrials.gov Identifier:
NCT01469598
First received: November 7, 2011
Last updated: December 28, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2015
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)